Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TearLab Corp (NASDAQ:TEAR)

0.5253
Delayed Data
As of Feb 24
 +0.0217 / +4.31%
Today’s Change
0.46
Today|||52-Week Range
9.70
-89.90%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$28.2M

Company Description

TearLab Corp. engages in the development and marketing of lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by testing disease markers in tears at the point-of-care. It also intends to measure the osmolarity of human tears to aid in the diagnosis of dry eye disease in patients suspected of having dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in San Diego, CA.

Contact Information

TearLab Corp.
9980 Huennekens Street
San Diego California 92121
P:(855) 832-7522
Investor Relations:
(647) 872-4849

Employees

Shareholders

Mutual fund holders9.89%
Other institutional26.23%
Individual stakeholders23.47%

Top Executives

Joseph JensenChief Executive Officer
Wes BrazellChief Financial Officer
Benjamin D. SullivanChief Scientific Officer
Michael A. LempChief Medical Officer
David Craig EldridgeVP-Clinical Affairs & Professional Development